10x Genomics, Inc. Class A

XNASHealth care

Last traded price · USD

$59.47

−11.92%Delayed

Delayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 21:14 IST · A quote does not mean the product is available to trade on your account.

Day's open: $61.64
Previous close: $67.52
Volume: 1.2M
Day's high: $63.40
Day's low: $58.85

In brief

10x Genomics, Inc. is a health care company listed on Nasdaq, valued at about $7.75B.
Its shares closed at $67.52 on 4 Nov 2026, up 405.4% over the past year.
From India you can buy TXG in US dollars under the RBI's Liberalised Remittance Scheme, including a fraction of one share. See what it costs

Questions investors ask

Can I buy 10x Genomics, Inc. (TXG) shares from India?

Yes. Indian residents can invest in the US stock market under the Reserve Bank of India's Liberalised Remittance Scheme (LRS), which lets a resident individual remit up to USD 250,000 per financial year, across all permitted purposes combined. US-listed stocks and ETFs are a permitted investment under the LRS. You are solely responsible for ensuring your remittances comply with the LRS annual limit, the applicable Tax Collected at Source (TCS) rules, and all reporting requirements, including Schedule FA in your income-tax return.

Do I need the price of a whole TXG share to invest?

Yes. You can buy fractional shares, which lets you invest a fixed rupee/dollar amount even in high-priced stocks. For example, if one share trades at USD 1,000 and you invest USD 100, you receive 0.1 of a share.

How much can I invest in US stocks in a year?

Under the LRS, an Indian resident can remit up to USD 250,000 per financial year (April to March) across all permitted purposes combined, from their own funds. This is a per-individual limit set by the RBI.

Can I trade TXG options or futures?

No. Under RBI / FEMA rules, the LRS does not permit margin trading or speculative instruments such as futures, options, or other derivatives. Your US account is a cash account, not a derivatives and margin account.

Insights

Quotes run fifteen minutes behind.

Ahead of SPY and its sector fund XLV over 1 year
1 month: −16.3% (SPY −1.6%, XLV +13.5%). 3 months: +42.3% (SPY −0.4%, XLV +15.5%). 1 year: +405.4% (SPY +13.6%, XLV +30.7%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: TXG, SPY and XLV · as of 4 Nov 2026
Short interest at 10.6% of shares outstanding
12.7M shares were sold short at the 15 Oct 2026 settlement, 10.6% of the 120.2M shares outstanding; covering them would take 2.6 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026
Below its 50-day average, above its 200-day
The 4 Nov 2026 close of $67.52 was 9.0% below its 50-day average ($74.19) and 63.8% above its 200-day average ($41.23). It has closed above the 200-day for 266 sessions, since 15 Oct 2025. The 50-day average crossed above the 200-day on 15 Aug 2025, 307 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026
61% of the way up its 52-week range
Closed at $67.52 on 4 Nov 2026: 34.3% below the 52-week high of $102.81 (6 Oct 2026) and 427.5% above the low of $12.80 (6 Nov 2025).
Daily price bars, split-adjusted · as of 4 Nov 2026

Returns

Price return, split-adjusted

At the 4 Nov 2026 close

1 month−16.3%

6 months+196.9%

1 year+405.4%

5 years−63.0%

Newswire

About

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives operates from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).

Website

Notable moves

April 9, 2025
+21.43%
October 10, 2024
−24.70%
November 10, 2022
+24.37%

Newswire

About

Website

Notable moves

April 9, 2025
+21.43%
October 10, 2024
−24.70%
November 10, 2022
+24.37%

10x Genomics, Inc. Class A

XNASHealth care

Last traded price · USD

$59.47

−11.92%Delayed

Delayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 21:14 IST · A quote does not mean the product is available to trade on your account.

Day's open: $61.64
Previous close: $67.52
Volume: 1.2M
Day's high: $63.40
Day's low: $58.85

In brief

10x Genomics, Inc. is a health care company listed on Nasdaq, valued at about $7.75B.
Its shares closed at $67.52 on 4 Nov 2026, up 405.4% over the past year.
From India you can buy TXG in US dollars under the RBI's Liberalised Remittance Scheme, including a fraction of one share. See what it costs

Questions investors ask

Can I buy 10x Genomics, Inc. (TXG) shares from India?

Do I need the price of a whole TXG share to invest?

How much can I invest in US stocks in a year?

Can I trade TXG options or futures?

Insights

Quotes run fifteen minutes behind.

Ahead of SPY and its sector fund XLV over 1 year
1 month: −16.3% (SPY −1.6%, XLV +13.5%). 3 months: +42.3% (SPY −0.4%, XLV +15.5%). 1 year: +405.4% (SPY +13.6%, XLV +30.7%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: TXG, SPY and XLV · as of 4 Nov 2026
Short interest at 10.6% of shares outstanding
12.7M shares were sold short at the 15 Oct 2026 settlement, 10.6% of the 120.2M shares outstanding; covering them would take 2.6 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026
Below its 50-day average, above its 200-day
The 4 Nov 2026 close of $67.52 was 9.0% below its 50-day average ($74.19) and 63.8% above its 200-day average ($41.23). It has closed above the 200-day for 266 sessions, since 15 Oct 2025. The 50-day average crossed above the 200-day on 15 Aug 2025, 307 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026
61% of the way up its 52-week range
Closed at $67.52 on 4 Nov 2026: 34.3% below the 52-week high of $102.81 (6 Oct 2026) and 427.5% above the low of $12.80 (6 Nov 2025).
Daily price bars, split-adjusted · as of 4 Nov 2026

Returns

Price return, split-adjusted

At the 4 Nov 2026 close

1 month−16.3%

6 months+196.9%

1 year+405.4%

5 years−63.0%

Newswire

About

Website

Notable moves

April 9, 2025
+21.43%
October 10, 2024
−24.70%
November 10, 2022
+24.37%

Newswire

About

Website

Notable moves

April 9, 2025
+21.43%
October 10, 2024
−24.70%
November 10, 2022
+24.37%

10x Genomics, Inc. Class A

10x Genomics, Inc. in brief

Ahead of SPY and its sector fund XLV over 1 year

Short interest at 10.6% of shares outstanding

Below its 50-day average, above its 200-day

61% of the way up its 52-week range

10x Genomics, Inc. Class A

10x Genomics, Inc. in brief

Ahead of SPY and its sector fund XLV over 1 year

Short interest at 10.6% of shares outstanding

Below its 50-day average, above its 200-day

61% of the way up its 52-week range